Literature DB >> 11110083

Transarterial embolisation of complex cavernous sinus dural arteriovenous fistulae with low-concentration cyanoacrylate.

H M Liu1, Y C Huang, Y H Wang, Y K Tu.   

Abstract

We report the effectiveness of low-concentration n-butyl-2-cyanoacrylate (NBCA)-Lipiodol-tungsten mixture (10-15 %) in the management of patients with aggressive or recurrent complex cavernous dural arteriovenous fistulae (CSDAVF). We treated five patients with complex CSDAVF with a low concentration of an NBCA-Lipiodol-tungsten mixture after catheterisation of the feeding arteries arising from the external carotid artery. Three had a recurrent CSDAVF after transarterial particulate embolisation. Three refused transvenous treatment or could not be treated in this way; two patients had also feeding dural branches of the internal carotid artery. All patients had complete resolution of symptoms and signs within a month of the procedure. No definite neurological complication was found during follow-up ranging from 12 to 36 months. Transarterial embolisation with low-concentration cyanoacrylate appears to be an effective alternative management of aggressive or recurrent CSDAVF.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11110083     DOI: 10.1007/s002340000405

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  14 in total

1.  Cavernous sinus dural fistula treated by transvenous facial vein approach.

Authors:  V Prochazka; V Cizek; R Kacirova
Journal:  Interv Neuroradiol       Date:  2004-10-22       Impact factor: 1.610

2.  Endovascular treatment for dural arteriovenous fistula of the anterior condylar vein with unusual venous drainage: report of two cases.

Authors:  Shuichi Tanoue; Katsuya Goto; Shinzo Oota
Journal:  AJNR Am J Neuroradiol       Date:  2005-09       Impact factor: 3.825

3.  Transarterial and transvenous embolization for cavernous sinus dural arteriovenous fistulae.

Authors:  J Zhang; X Lv; C Jiang; Y Li; X Yang; Z Wu
Journal:  Interv Neuroradiol       Date:  2010-10-25       Impact factor: 1.610

4.  Occlusion of a clival dural arteriovenous fistula using a novel approach through the foramen ovale.

Authors:  Alfonso Urdaneta-Moncada; Lei Feng; Joseph Chen
Journal:  BMJ Case Rep       Date:  2012-11-19

5.  A promising adjuvant to detachable coils for cavernous packing: onyx.

Authors:  X Lv; C Jiang; Y Li; Z Wu
Journal:  Interv Neuroradiol       Date:  2009-09-01       Impact factor: 1.610

6.  Transvenous injection of Onyx for casting of the cavernous sinus for the treatment of a carotid-cavernous fistula.

Authors:  Anil Arat; Saruhan Cekirge; Isil Saatci; Burce Ozgen
Journal:  Neuroradiology       Date:  2004-11-09       Impact factor: 2.804

7.  Percutaneous Transvenous Embolization of Intracranial Dural Arteriovenous Fistulas with Detachable Coils and/or in Combination with Onyx.

Authors:  Xianli Lv; Chuhan Jiang; Youxiang Li; Xinjian Yang; Zhongxue Wu
Journal:  Interv Neuroradiol       Date:  2009-01-05       Impact factor: 1.610

8.  Treatment of dural arteriovenous fistulas.

Authors:  Vasilios Katsaridis
Journal:  Curr Treat Options Neurol       Date:  2009-01       Impact factor: 3.598

9.  Cavernous sinus dural fistulae treated by transvenous approach through the facial vein: report of seven cases and review of the literature.

Authors:  Alessandra Biondi; Dan Milea; Christophe Cognard; Giuseppe K Ricciardi; Fabrice Bonneville; Rémy van Effenterre
Journal:  AJNR Am J Neuroradiol       Date:  2003 Jun-Jul       Impact factor: 3.825

10.  Long-Term Endovascular Treatment Outcome of 46 Patients with Cavernous Sinus Dural Arteriovenous Fistulas Presenting with Ophthalmic Symptoms. A Non-Controlled Trial with Clinical and Angiographic Follow-up.

Authors:  Ali Pashapour; Reza Mohammadian; Firooz Salehpour; Ehsan Sharifipour; Reza Mansourizade; Ali Mahdavifard; Mohamadgharib Salehi; Farhad Mirzaii; Payam Sariaslani; Ghasem Fatahzade Ardalani; Davar Altafi
Journal:  Neuroradiol J       Date:  2014-08-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.